Abstract:ObjectiveTo explore the nutritional status of patients underwent haploid hematopoietic stem cell transplantation (HSCT) before and after transplantation, and to provide evidence for clinical nutritional intervention among post transplantation patients. Methods Forty-seven patients with hematological diseases received haploidentical allo-HSCT from July 2015 to June 2017 in the First Hospital of Jilin University were enrolled in present study. The patient-generated subjective global assessment (PG-SGA) and human component analysis were assessed before transplantation and 30, 90,180 days after transplantation respectively. ResultsThe body weight, body mass index (BMI), fat-free mass, peripheral diameter of the left leg and mid-arm circumference decreased significantly at 30 days after transplantation, while fat mass increased but showed no statistical significance. Some indexes began to recover at 180 days after transplantation, but still lower than those before transplantation (all P<0.05). According to the PG-SGA evaluation, malnutrition was as high as 95.56% in patients 30 days after transplantation, and recovered at 180 days after transplantation but still higher than those before transplantation (P<0.05). In the early stage of transplantation, there were differences in weight and fat-free mass changes between men and women (P<0.05). In particular, the proportion of weight loss in men at 30 days after transplantation was much higher than that in women, and men were more likely to have nutritional problems than women. ConclusionMalnutrition may occur in all patients after haploidentical allo-HSCT, and the nutritional assessment of the patients was more accurate and comprehensive by PG-SGA and human composition analysis.
贾艳雪,谭业辉,高素君,李薇,彭昳. 单倍体造血干细胞移植患者移植前后营养状况动态变化[J]. 肿瘤代谢与营养电子杂志, 2019, 6(4): 436-441.
JIA Yan-xue, TAN Ye-hui, GAO Su-jun, LI Wei, PENG Yi. Changes of nutritional status in hematological patients before and after haploid hematopoietic stem cell transplantation. Electron J Metab Nutr Cancer, 2019, 6(4): 436-441.
1.Chang YJ, Hang XJ. Haploidentical stem cell transplantation: anti-thymocyte globulin-based experience. Semin Hematol. 2016;53(2):82-89.
2.Norkin M, Wingard JR. Recent advances in hematopoietic stem cell transplantation. F1000Res. 2017;6(6):870.
3.Kanakry CG, Fuchs EJ, Luznik L. Modern approaches to HLA-haploidentical blood or marrow transplantation. Nat Rev Clin Oncol. 2016;13(2):132.
4.常英军,张圆圆. 异基因造血干细胞移植相关研究进展. 白血病·淋巴瘤. 2018;27(2):65-68.
5.Aoyama T, Imataki O, Mori K,et al. Nutritional risk in allogeneic stem cell transplantation: rationale for a tailored nutritional pathway. Ann Hematol. 2017;96:617-625.
6.Baumgartner A, Bargetzi A, Zueger N,et al. Revisiting nutritional support for allogeneic hematologic stem cell transplantation-a systematic review. Bone Marrow Transplant. 2017;52(4):506-513.
7.Fuji S, Mori T, Khattry N, et al. Severe weight loss in 3 months after allogeneic hematopoietic SCT was associated with an increased risk of subsequent non-relapse mortality. Bone Marrow Transplant. 2015;50(1):100-105.
8.Krawczyk J, Kraj L, Korta T, et al. Nutritional status of hematological patients before hematopoietic stem cell transplantation and in early posttransplantation period. Nutr Cancer. 2017;69(8):1205-1210.
9.Verdi Schumacher M, Moreira Faulhaber GA. Nutritional status and hyperglycemia in the peritransplant period: a review of associations with parenteral nutrition and clinical outcomes. Rev Bras Hematol Hemoter. 2017;39(2):155-162.
10.Chen XH, Gao L, Zhang X, et al. HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: long-term comparison with HLA-identical sibling transplantation. Blood Cells Mol & Dis. 2009;43(1):98-104.
11.苏龙, 刘晓亮, 谭业辉, 等. 单倍体与同胞全相合造血干细胞移植治疗恶性血液病的疗效与并发症分析. 中华器官移植杂志.2016;37(11):672-676.
12.赵明利, 李宁. 人体成分分析及其应用. 肠外与肠内营养. 2016;23(1):50-54.
13.Sergi G, De Rui M, Stubbs B, et al. Measurement of lean body mass using bioelectrical impedance analysis: a consideration of the pros and cons. Aging Clin Exp Res. 2017;29(4):591-597.
14.Hettiarachchi J, Madubhashini P, Miller M. Agreement between the malnutrition universal screening tool and the patient-generated subjective global assessment for cancer outpatients receiving chemotherapy: a cross-sectional study. Nutr Cancer. 2018;70(8):1275-1282.
15.中国抗癌协会肿瘤营养与支持治疗专业委员会组织编写. 中国肿瘤营养治疗指南. 北京:人民卫生出版社,2015.
16.El-Ghammaz AMS, Ben Matoug R, Elzimaity M,et al. Nutritional status of allogeneic hematopoietic stem cell transplantation recipients: influencing risk factors and impact on survival. Support Care Cancer. 2017;25(10):3085-3093.
17.Fuji S, Einsele H, Savani BN, et al. Systematic nutritional support in allogeneic hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant. 2015;21(10):1707-1713.
18.Urbain P, Birlinger J, Lambert C, et al. Longitudinal follow-up of nutritional status and its influencing factors in adults undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2013;48(3):446-451.
19.Garios RS, Oliveira PM, Aguiar AS, et al. Caloric and protein intake in different periods of hospitalization of patients undergoing hematopoietic stem cell transplantation. Hematol Transfus Cell Ther. 2018;40(4):332-338.
20.中华医学会肠外肠内营养学分会. 肿瘤患者营养支持指南. 中华外科杂志. 2017;55(11):801-829.
21.李世林, 宋英丽, 唐玉芳. 晚期癌症患者营养状况调查及肠内肠外营养支持效果比较. 现代肿瘤医学. 2016;191(5):115-118.
22.石汉平. 肿瘤营养疗法. 中国肿瘤临床. 2014;41(18):1141-1144.
23.贾震易. 家居肿瘤患者的口服营养补充. 肿瘤代谢与营养电子杂志. 2015;2(1):19-22.
24.Garios RS, Oliveira PM, Aguiar AS, et al. Caloric and protein intake in different periods of hospitalization of patients undergoing hematopoietic stem cell transplantation. Hematol Transfus Cell Ther. 2018;40(4):332-338.
25.Tanaka S, Imataki O, Kitaoka A, et al. Clinical impact of sarcopenia and relevance of nutritional intake in patients before and after allogeneic hematopoietic stem cell transplantation. J Cancer Res Clin Oncol. 2017;143(6):1083-1092.
26.Hung YC, Bauer J, Horsley P, et al. Changes in nutritional status, body composition, quality of life, and physical activity levels of cancer patients undergoing autologous peripheral blood stem cell transplantation. Support Care Cancer. 2013;21(6):1579-1586.
27.Brotelle T, Lemal R, Cabrespine A, et al. Prevalence of malnutrition in adult patients previously treated with allogeneic hematopoietic stem-cell transplantation.Clin Nutr. 2018;37(2):739-745.
28.Chow EJ, Pihoker C, Friedman DL, et al. Glucocorticoids and insulin resistance in children with acute lymphoblastic leukemia. Pediat Blood Cancer. 2013;60(4):621-626.
29.Kyle UG, Chalandon Y, Miralbell R, et al. Longitudinal follow-up of body composition in hematopoietic stem cell transplant patients. Bone Marrow Transplant. 2005;35(12):1171-1177.
30.Mostoufi-Moab S, Magland J, Isaacoff EJ, et al. Adversefat depots and marrow adiposity are associated with skeletal deficits and insulin resistance in long-term survivors of pediatric hematopoietic stem cell transplant. J Bone Miner Res. 2015;30(9):1657-1666.
31.Mostoufi-Moab S, Ginsberg JP, Bunin N, et al. Body composition abnormalities in long-term survivors of pediatric hematopoietic stem cell transplantation. J Pediatr. 2012;160(1):122-128.
32.马怀幸, 李苏宜. 肿瘤厌食发生机制及其诊治. 肿瘤代谢与营养电子杂志. 2018;5(2):14-18.
33.Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med. 2006;173(1):79-83.
34.Steinberg A, Asher A, Bailey C, et al. The role of physical rehabilitation in stem cell transplantation patients. Support Care Cancer. 2015;23(8):2447-2460.
35.Liberman K, Forti LN, Beyer I, et al. The effects of exercise on muscle strength, body composition, physical functioning and the inflammatory profile of older adults: a systematic review. Curr Opin Clin Nutr Metab Care. 2017;20(1):30-53.
36.Nikolousis E, Nagra S, Paneesha S, et al. Allogeneic transplant outcomes are not affected by body mass index (BMI) in patients with haematological malignancies. Ann Hematol. 2010;89(11):1141-1145.
37.Le Blanc K, Ringden O, Remberger M. A low body mass index is correlated with poor survival after allogeneic stem cell transplantation. Haematologica. 2003;88(9):1044-1052.
38.Yang J, Xue SL, Zhang X, et al. Effect of body mass index on overall survival of patients with allogeneic hematopoietic stem cell transplantation. Eur J Clin Nutr.2017;71(6):750-754.
39.Pena NF, Mauricio SF, Rodrigues AMS, et al. Association between standardized phase angle, nutrition status, and clinical outcomes in surgical cancer patients. Nutr Clin Pract. 2019;34(3):381-386.
40.Grundmann O, Yoon SL, Williams JJ.The value of bioelectrical impedance analysis and phase angle in the evaluation of malnutrition and quality of life in cancer patients-a comprehensive review. Eur J Clin Nutr. 2015;69(12):1290-1297.
41.Barritta de Defranchi RL, Bordalejo A, Caueto I, et al. Evolution of nutritional status in patients with autologous and allogeneic hematopoietic stem cell transplant. Support Care Cancer. 2015;23(5):1341-1347.
42.Iestra JA, Fibbe WE, Zwinderman AH, et al. Body weight recovery, eating difficulties and compliance with dietary advice in the first year after stem cell transplantation: a prospective study. Bone Marrow Transplant. 2002;29(5):417-424.
43.Jing C, Xiaowen T, Wei C, et al. Effect of disease status on outcome of allogeneic hematopoietic stem cell transplantation in treatment of refractory and relapsed acute lymphoblastic leukemia. Blood. 2016;128 (22):5862.